Stay updated on Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4, a minor maintenance update with no changes to core study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:06:24.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Locations sections were reorganized: a general Locations entry was added with multiple regional sites (Arizona, California, Connecticut, New York, Ohio, Oregon, Tennessee, Texas, Virginia, Washington, Victoria, MI, RM) and the page was updated to Revision: v3.3.3. Several individual location subsections were removed, and the HHS Vulnerability Disclosure link was deleted.
    Difference
    0.9%
    Check dated 2025-12-24T16:53:53.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    PubMed auto-fill note added and revision updated to v3.3.2; older PubMed-derived note and revision reference v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T21:10:05.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The notice about a lapse in government funding has been removed from the page. This banner was operational and did not affect the study details.
    Difference
    0.2%
    Check dated 2025-11-18T19:01:55.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Study Details page appears unchanged in substantive content; the overall structure and sections (Brief Summary, Eligibility Criteria, Interventions, Location, and Contacts) look the same with only minor UI differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T12:53:11.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added MedlinePlus Genetics topic on ovarian cancer to the page, expanding core content with a genetics-focused disease entry.
    Difference
    0.1%
    Check dated 2025-10-20T06:45:57.000Z thumbnail image

Stay in the know with updates to Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.